Skip to main content
InnoCare Pharma Limited logo

InnoCare Pharma Limited — Investor Relations & Filings

Ticker · 9969 ISIN · KYG4783B1032 LEI · 3003001NYJPPWIEOJT79 HKEX Manufacturing
Open in API
Filings indexed 428 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 9969

About InnoCare Pharma Limited

http://www.innocarepharma.com

InnoCare Pharma Limited is a commercial stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative drugs. The company focuses primarily on creating potentially best-in-class and first-in-class therapies for the treatment of cancer (oncology) and autoimmune diseases. InnoCare researches, develops, and commercializes its pipeline with the goal of delivering safe and effective treatments to patients globally.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-04-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The document is extremely short (only 242 characters) and merely announces that an issuer’s announcement has been published in another section. It contains no financial data, no meeting materials, and no detailed report—only a notice of publication. Under the “menu vs meal” rule, this is a report publication announcement rather than the report itself.
2026-04-24 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Form of Proxy” for the upcoming Annual General Meeting, which is used to solicit and record shareholders’ voting instructions. This falls under Proxy Solicitation & Information Statement (PSI), not the AGM presentation itself or the AGM notice. The content is specifically a proxy form to request votes.
2026-04-24 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 1% confidence The document is the official Notice of the Annual General Meeting of InnoCare Pharma Limited, detailing the date, venue, and a full agenda of ordinary and special resolutions to be considered by shareholders. It does not present full financial statements as in an Annual Report nor is it seeking votes in a proxy or circular form, and it is clearly related to the AGM itself. Therefore, it falls under the AGM Information category.
2026-04-24 English
2025 AGM Circular
Regulatory Filings
2026-04-24 English
PROPOSED ADOPTION OF THE 2026 RMB SHARE INCENTIVE SCHEME AND THE SCHEME MANDATE LIMIT
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory announcement under the Hong Kong Exchange detailing proposed resolutions at the forthcoming AGM to adopt a new RMB Share Incentive Scheme, including the issuance and grant of new shares under that scheme. It specifically addresses share issuance parameters and scheme mandate limits rather than delivering full AGM materials or quarterly results. This most closely aligns with our Share Issue/Capital Change category, which covers announcements regarding new share issues or other capital changes.
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.